Inactive Instrument

News Algeta ASA Other OTC

Equities

NO0010239437

End-of-day quote Other OTC Other stock markets
- ^USD	-

2014	Actavis : Factbox - M&A frenzy transforming global pharma	RE
2014	Actavis : M&A frenzy in healthcare sector	RE

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Actavis : Factbox - M&A frenzy transforming global pharma	14-05-06	RE
Actavis : M&A frenzy in healthcare sector	14-05-06	RE
Algeta ASA : UK cost agency says 'no' to Bayer prostate cancer drug Xofigo	14-03-23	RE
Algeta ASA : Bayer clinches $2.9 billion deal for Norway's Algeta	14-02-24	RE
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid	13-12-19	RE
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid	13-12-19	RE
OTSUKA CORPORATION : Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta	13-11-26	RE
OTSUKA CORPORATION : Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta	13-11-26	RE
Bayer AG : Bayer says does not want to provide details on Algeta offer	13-11-26	RE
Algeta ASA : Algeta to host Capital Markets Days	13-11-18	PU
Algeta ASA : CORRECTION: Algeta ASA : Algeta Results for the Third Quarter 2013	13-11-08	PU
Algeta ASA : Algeta's Financial Calendar 2014	13-11-08	PU
Algeta ASA : Algeta to Participate in Upcoming Investor Conferences	13-11-05	PU
Algeta ASA : Algeta Schedules Third Quarter 2013 Results Presentation, Webcast and Conference Call	13-10-28	PU
Algeta ASA : New data and analyses from the phase III ALSYMPCA trial of radium Ra 223 dichloride to be presented at the European Cancer Congress (ECCO-ESMO-ESTRO) 2013	13-09-12	PU
Algeta ASA : Algeta results for the First Half and Second Quarter 2013	13-08-28	PU
Algeta ASA : Algeta Appoints Dr Andreas Menrad as Chief Scientific Officer	13-08-19	PU
Algeta ASA : Algeta schedules first half and second quarter 2013 results presentation, webcast and conference call	13-08-19	PU
Algeta ASA : Algeta to Participate in Upcoming Investor Conferences	13-08-12	PU
Algeta ASA : Algeta celebrates the official opening of its commercial production facility for Xofigo® (radium Ra 223 dichloride) at the Institute for Energy Technology (IFE) in Norway	13-06-20	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Algeta ASA Other OTC

Equities

NO0010239437

Summary

Filters